This New Novartis AG Drug May Revolutionize Heart Failure Treatment
Novartis LCZ696 may give doctors the first significant high blood pressure drug approved in decades if regulators give it the okay next year.
Is It Time to Buy Johnson & Johnson's Stock?
Successful new drug launches have fueled Johnson & Johnson's run, but is there enough left in the tank for shares to continue heading higher?
Is It Time to Buy Pfizer Inc.'s Stock?
Pfizer stock has more than doubled since the recession lows. Can its shares head even higher or should investors be looking to lock in their gains?
Why Google Wants to Map Your Body With Its Baseline Study
Google recently announced that it will collect genetic information from thousands of people to “map out” the healthy human body. Here’s what you need to know about the Google Baseline Study.